See Our Current Investments

BIOTECHNOLOGY

June 15th

eSense-Lab strikes JV to develop and a sell new range of terpene products
GTG developing a genetic test in the fight against COVID-19

May 22nd 2020

GTG developing a genetic test in the fight against COVID-19
Plenty of run left in Genetic Signatures

May 11th 2020

Plenty of run left in Genetic Signatures
Proteomics awarded vital CE Mark registration for PromarkerD

April 16th 2020

Proteomics awarded vital CE Mark registration for PromarkerD
Genetic Signatures builds on SARS technology

March 30th 2020

Genetic Signatures builds on SARS technology
Regeneus surges on back of Progenza patent news

March 23rd 2020

Regeneus surges on back of Progenza patent news
Knee osteoarthritis treatment delivers Regeneus a A$1.6M milestone payment

March 20th 2020

Knee osteoarthritis treatment delivers Regeneus a A$1.6M milestone payment
OncoSil granted FDA Breakthrough Device Designation

March 18th 2020

OncoSil granted FDA Breakthrough Device Designation
Regeneus inks agreement with high profile Japanese life sciences group

March 3rd 2020

Regeneus inks agreement with high profile Japanese life sciences group

Subscribe for updates on our small cap, ASX listed biotech portfolio.

Thanks for subscribing!

X